Skip to content

Writing About Disease: Effect on Rehabilitation?

Writing About Disease: Effect on Rehabilitation?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00251420
Enrollment
180
Registered
2005-11-10
Start date
2005-12-31
Completion date
2007-12-31
Last updated
2009-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, COPD

Keywords

copd, asthma, QoL, Perceived health status, Trait anxiety

Brief summary

Therapeutic writing about one's emotions has been described previously (J Pennebaker: Emotions, disclosure and health. Am Psychol. Assoc 1995). The present project will compare the effects (if any) of writing about the emotional versus the physical consequences of lung disease on anxiety, perceived quality of life, and perceived health status.

Detailed description

Chronic obstructive pulmonary disease (COPD) patients (age 35-70) and asthma patients (age 20-60) referred to a 4 weeks inpatient rehabilitation program - who agree to participate in the project - are randomly assigned to one of three conditions: * Writing about emotional consequences of their disease before the program starts * Writing about physical consequences of their disease before the program starts * Not writing All patients are measured (completing questionnaires at home) on: perceived quality of life, perceived health status and trait anxiety - 2 weeks before the program, 2 weeks after the program and 6 months after the program. FEV1 and 6 min walking distance are measured at the beginning and by the end of the program. In addition to questionnaires, all patients are asked to: * Write in their own words ( 2 weeks after) to evaluate their stay at the rehabilitation clinic; and * Write in their own words (6 months after) about how the disease affects their life at that point. Both quantitative and qualitative data will be used for analysis purposes.

Interventions

PROCEDUREwriting about disease

writing about physical or emotional consequences of pulmonary disease

Sponsors

The norwegian association for heart and lung patients
CollaboratorUNKNOWN
LHL Helse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of COPD (age between 35 and 70) * Clinical diagnosis of asthma (age between 20 and 60)

Design outcomes

Primary

MeasureTime frame
Quality of lifeprospective
Perceived health statusprospective
Trait anxietyprospective

Secondary

MeasureTime frame
Forced expiratory volume in 1 second (FEV1)prospective
6-minute walking distanceprospective

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026